MOLECULAR CHARACTERIZATION OF MBL IN UROPATHOGENIC E. COLI ISOLATED FROM PATIENTS OF TERTIARY CARE HOSPITAL
DOI:
https://doi.org/10.55519/JAMC-04-13466Keywords:
Urinary tract infection; Escherichia coli; Extended spectrum Beta lactamase (ESBL); Metallo beta lactamase (MBL)Abstract
Background: Antibiotic resistance is on an increasing trend, particularly in gram-negative bacteria. The production of metallo β-lactamase (MBL) puts the health sector at great risk as it further limits the treatment option for MDR strain. MBL is mostly reported in Enterobacteriaceae, which poses resistance to almost all β-lactam antibiotics except monobactam. The current study aims to determine the prevalence, antibacterial sensitivity pattern, and molecular characterization of MBL in Uropathogenic E. coli from clinical samples of hospitalized patients in Khyber Pakhtunkhwa. Methods: From tertiary care hospitals in Peshawar, 250 Urine samples were collected from indoor hospitalized patients. Gold standard microbiological methods were used to identify UPEC from these clinical samples.For that,urine samples was inoculated onto Cysteine Lactose Electrolyte. Deficient (CLED) agar plate, and MacConkey Agar.Positive growth of E.coli identified through Gram staining, colony morphology, Biochemical Tests and E.coli 16srRNA gene amplification .Antibiotic sensitivity was determined by the disc diffusion method on Muller Hinton agar. For the detection of MBL production double disc synergy, and a combination disc test of the antibiotics were used. Furthermore, multiplex PCR was used for the molecular characterization of the MBL (blaIMP, blaVIM, and blaNDM) genes. Results: Of the 250 samples, only 110 samples were confirmed as Uropathogenic E. coli based on colonial morphology, biochemical testing, and molecular level by targeting the 16SrDNA. Female was found more susceptible to UTI compared to male. High prevalence was found in the age group 45-65 years. UPEC was found highly resistance to Ciprofloxacin (90%), followed by Cefotaxime and Ceftriaxone (86%), Ceftazidime and Augmentin (81%), Tazobactam (61%). while the lowest resistance was reported against Meropenum (20%) Imipenem (18%) and Amikacin (37%). PCR-based confirmed prevalence of MBL encoding genes was blaNDM (42%), blaVIM (32%), and blaIMP (26%). Conclusion: The study proposed a higher prevalence of urinary tract infections (UTIs) in females aged group 54-65 years compared to males. An analysis of antibiotic sensitivity revealed Imipenem and Meropenem to be the most effective antimicrobial agents, while Ciprofloxacin, Cefotaxime and Amoxicillin were found to be the less effective. UPEC were found highly resistance to Ciprofloxacin 91%, and ceftazidime 86%, while comparatively less resistance to meropenem, and imipenem,20% and 18% respectively. Genotype BlaNDM of the MBL is highly prevalent (42%) among UPEC.Furthermore, the presence of MBL genes was detected in over 19% of UPEC, and in different combinations.The upraise of the MBLs resistance in uropathogenic E. coli is an alarming sign for clinicians to decide on treatment options for complicated UTIs.
References
1. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: Epidemiology, mechanisms of infec-tion and treatment options. Nat Rev Microbiol 2015;13(5):269–84.
2. Luna-Pineda V, Ochoa S, Cruz Córdova A, Cázares V, Vélez F, Hernández-Castro R, et al. [Urinary tract infections, im-munity, and vaccination]. Bol Méd Hosp Infant Méx 2018;75(2):67–78.
3. Morris S, Cerceo E. Trends, epidemiology, and management of multi-drug resistant gram-negative bacterial infections in the hospitalized setting. Antibiotics (Basel) 2020;9(4):196.
4. Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, Cop-polino F, et al. Mechanisms of action of carbapenem re-sistance. Antibiotics (Basel) 2022;11(3):421.
5. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneu-moniae sequence type 14 from India. Antimicrob Agents Chemother 2009;53(12):5046–54.
6. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007;20(3):440–58.
7. Poirel L, Dortet L, Bernabeu S, Nordmann P. Genetic features of bla NDM-1-positive Enterobacteriaceae. Antimicrob Agents Chemother 2011;55(11):5403–7.
8. Zangane Matin F, Rezatofighi SE, Roayaei Ardakani M, Akhoond MR, Mahmoodi F. Virulence characterization and clonal analysis of uropathogenic Escherichia coli metallo-beta-lactamase-producing isolates. Ann Clin Microbiol An-timicrob 2021;20(1):50.
9. Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, Cop-polino F, et al. Mechanisms of action of carbapenem re-sistance. Antibiotics (Basel) 2022;11(3):421.
10. Oelschlaeger P, Mayo SL. Hydroxyl groups in the ββ sand-wich of metallo-β-lactamases favor enzyme activity: a com-putational protein design study. J Mol Biol 2005;350(3):395–401
11. Isenberg HD. Clinical Microbiology Procedures Handbook, 2nd ed. ASM Press, Washington, DC; 2004.
12. Gautam V, Singhal L, Arora S, Jha C, Ray P. Reliability of KirbyBauer disk diffusion method for detecting carbapenem resistance in Acinetobacter baumannii-calcoaceticus com-plex isolates. Antimicrob Agents Chemother 2013;57(4):2003–4.
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: twenty-eighth informational supplement. Document M100-S28. Wayne, PA: [Internet]. CLSI. 2018 [cited 2024 May]. Availa-ble from: https://clsi.org/media/1930/m100ed28_sample.pdf
14. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Mi-crobiol Infect Dis 2011;70(1):119–23.
15. Zhu C, Wang DQ, Zi H, Huang Q, Gu JM, Li LY, et al. Epi-demiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and terri-tories from 1990 to 2019. Mil Med Res 2021;8(1):64.
16. Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, Cop-polino F, et al. Mechanisms of action of carbapenem re-sistance. Antibiotics (Basel) 2022;11(3):421.
17. Sadeghi A, Halaji M, Fayyazi A, Havaei SA. Characterization of plasmid-mediated quinolone resistance and serogroup dis-tributions of uropathogenic Escherichia coli among Iranian kidney transplant patients. BioMed Res Int 2020;2020:2850183.
18. Nwokolo CJ, Ugwu MC, Ejikeugwu CP, Iroha IR, Esimone CO. Incidence and antibiotic susceptibility profile of uro-pathogenic Escherichia coli positive for extended spectrum β-lactamase among HIV/AIDS patients in Awka metropolis, Nigeria. Iranian J Microbiol 2022;14(3):334–40.
19. Skrzat-Klapaczyńska A, Matłosz B, Bednarska A, Paciorek M, Firląg-Burkacka E, Horban A. Factors associated with urinary tract infections among HIV-1 infected patients. PLoS One 2018;13(1):e0190564.
20. Tüzün T, Kutlu SS, Kutlu M, Kaleli İ. Risk factors for com-munity-onset urinary tract infections caused by extended-spectrum ß-lactamase-producing Escherichia coli. Turkish J Med Sci 2019;49(4):1206–11.
21. Ehsan B, Haque A, Qasim M, Ali A, Sarwar Y. High preva-lence of extensively drug resistant and extended spectrum beta lactamases (ESBLs) producing uropathogenic Esche-richia coli isolated from Faisalabad, Pakistan. World J Mi-crobiol Biotechnol 2023;39(5):132.
22. Ahmed N, Khalid H, Mushtaq M, Basha S, Rabaan AA, Garout M, et al. The molecular characterization of virulence determinants and antibiotic resistance patterns in human bacterial uropathogens. Antibiotics (Basel) 2022;11(4):516.
23. Kar B, Sharma M, Peter A, Chetia P, Neog B, Borah A, et al. Prevalence and molecular characterization of β-lactamase producers and fluoroquinolone resistant clinical isolates from North East India. J Infect Public Health 2021;14(5):628–37.
24. Contreras-Alvarado LM, Zavala-Vega S, Cruz-Córdova A, Reyes-Grajeda JP, Escalona-Venegas G, Flores V, et al. Mo-lecular epidemiology of multidrug-resistant uropathogenic Escherichia coli O25b strains associated with complicated urinary tract infection in children. Microorganisms 2021;9(11):2299.
25. Cai Y, Chen C, Zhao M, Yu X, Lan K, Liao K, et al. High prevalence of metallo-β-lactamase-producing Enterobacter cloacae from three tertiary hospitals in China. Front Micro-biol 2019;10:1610.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Sabahat Asghar, Abid Ali Khuwaj, Muhammad Arfat, Noreen Taj, Maria Akhtar
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
